EP 3 725 778 B1 relates to solid formulations of enzalutamide. More particularly, this disclosure relates to pharmaceutical compositions comprising a solid dispersion containing enzalutamide and at least one polymer.
EP 3 725 778 B1 is a divisional application of EP 2 895 463 A1, originally published under WO 2014/043208.